论著

基于红细胞膜修饰的聚合物载体搭载的纳米靶向药物在骨再生和血管生成中的作用

Bone-targeted nanomedicine based on red blood cell membrane-coated polymeric carriers for bone regeneration and vascularization

:1621-1629
 
       目的   开发一种多功能纳米颗粒输送系统来刺激骨再生和血管形成,用于逆转骨质疏松症。方法   通过制备基于外消旋聚乳酸 Poly(D,L-lactide)即PLA的纳米颗粒来封装淫羊藿苷。随后,通过红细胞膜包被这些纳米颗粒以增强生物相容性。为了提高靶向特异性,进一步合成了由阿仑膦酸盐修饰的聚乙二醇-磷脂酰乙醇胺(PEG-DSPE) 组成的骨靶向聚合物脂质,并将其掺入细胞膜涂层中。结果   多功能纳米颗粒输送系统可通过调节骨髓间充质干细胞 (BMSC)功能,从而增强成骨和血管生成能力。结论   本研究结果表明,多功能纳米颗粒输送系统可以在体外刺激骨形成和血管形成,表明其有成为骨质疏松症先进治疗策略的潜力。
       Objective  To developed a multifunctional nanoparticle system to stimulate bone regeneration and vascularization as a therapeutics strategy for osteopovost.Methods  Poly(D,L-lactide)(PLA)-based nanoparticles were fabricated to encapsulate the icariin,which is renowned for its osteogenic potential.These nanoparticles were then coated with  red blood cell membranes to enhance biocompatibility.To further improve targeting specificity,a bone-targeted polymer-lipid consisting of alendronate-modified PEG-DSPE was synthesized and incorporated into the cell membrane coating.Results  The delivery system was designed to modulate the function of bone marrow mesenchymal stem cells,thereby enhancing both osteogenesis and angiogenesis.Conclusions  Our findings demonstrated that the therapeutic system could enhance bone formation and vascularization in vitro,indicating its potential as an advanced treatment strategy for osteoporosis.
论著

SUZ12通过调控肝癌细胞及人脐静脉内皮细胞的血管生成发挥抑癌作用

Anti-cancer role of SUZ12 by regulating angiogenesis of liver cancer cells and human umbilical vein endothelial cells

:71-76
 
目的 探讨多梳蛋白SUZ12对肝细胞肝癌(HCC)细胞增殖、血管生成拟态形成和人脐静脉内皮细胞(HUVECs)血管生成的影响。方法 分别利用MTT比色法及体外血管生成实验检测SUZ12表达水平改变对HCC细胞SMMC-7721、Hep3B增殖、血管生成拟态形成和HUVECs血管生成的影响。结果 MTT结果显示,在HCC细胞中分别敲低或过表达SUZ12均对HCC细胞的增殖能力无明显影响。将SUZ12低表达HCC细胞与HUVECs共培养后,HCC细胞的血管生成拟态管样结构形成增多。此外,将SUZ12敲低组HCC细胞的培养上清用于培养HUVECs后,HUVECs的血管生成拟态管样结构形成也明显增多。结论 SUZ12对HCC细胞的增殖无影响,其在HCC中可抑制HCC细胞和HUVECs的血管生成拟态管样结构形成。上述结果提示SUZ12可能通过调控HCC细胞及HUVECs的血管生成发挥抑癌作用。
Objective To investigate the effects of SUZ12 on cell proliferation of hepatocellular carcinoma(HCC),vasculogenic mimicry formation and human umbilical vein endothelial cells(HUVECs)angiogenesis.Methods MTT assay was performed to detect the proliferation of SMMC-7721 and Hep3B cells.The effects of SUZ12 on the angiogenesis of HCC cells and HUVECs cells were studied by in vitro angiogenesis experiment.Results The result of MTT assay showed that SUZ12 knockdown or overexpression in HCC cells had no significant effect on the proliferation of HCC cells.We found that when HCC cells with low SUZ12 expression were co-cultured with HUVECs cells,the formation of vasculogenic mimicry tubular structures in HCC cells increased.In addition,we also found that after the culture supernatant of HCC cells in the SUZ12 knockdown group was used to culture HUVECs cells,the formation of vasculogenic mimicry tubular structures in HUVECs cells also increased significantly.Conclusions SUZ12 has no effect on the proliferation of HCC cells,but it can inhibit the formation of vasculogenic mimicry tubular structures in HCC cells and HUVECs cells.These results suggest that SUZ12 plays a role in cancer inhibition by regulating the angiogenesis of HCC cells and HUVECs cells.
论著

SUZ12 通过调控肝癌细胞及人脐静脉内皮细胞的血管生成发 挥抑癌作用

Anti-cancer role of SUZ12 by regulating angiogenesis of liver cancer cells and human umbilical vein endothelial cells

:71-76
 
       目的   探讨多梳蛋白SUZ12对肝细胞肝癌(HCC)细胞增殖、血管生成拟态形成和人脐静脉内皮细胞(HUVECs)血管生成的影响。方法 分别利用MTT比色法及体外血管生成实验检测SUZ12表达水平改变对HCC细胞SMMC-7721、Hep3B增殖、血管生成拟态形成和HUVECs血管生成的影响。结果  MTT结果显示,在HCC细胞中分别敲低或过表达SUZ12均对HCC细胞的增殖能力无明显影响。将SUZ12低表达HCC细胞与HUVECs共培养后,HCC细胞的血管生成拟态管样结构形成增多。此外,将SUZ12敲低组HCC细胞的培养上清用于培养HUVECs后,HUVECs的血管生成拟态管样结构形成也明显增多。结论  SUZ12对HCC细胞的增殖无影响,其在HCC中可抑制HCC细胞和HUVECs的血管生成拟态管样结构形成。上述结果提示SUZ12可能通过调控HCC细胞及HUVECs的血管生成发挥抑癌作用。
      Objective  To investigate the effects of SUZ12 on cell proliferation of hepatocellular carcinoma(HCC),vasculogenic mimicry formation and human umbilical vein endothelial cells(HUVECs)angiogenesis.Methods  MTT assay was performed to detect the proliferation of SMMC-7721 and Hep3B cells.The effects of SUZ12 on the angiogenesis of HCC cells and HUVECs cells were studied by in vitro angiogenesis experiment.Results  The result of MTT assay showed that SUZ12 knockdown or overexpression in HCC cells had no significant effect on the proliferation of HCC cells.We found that when HCC cells with low SUZ12 expression were co-cultured with HUVECs cells,the formation of vasculogenic mimicry tubular structures in HCC cells increased.In addition,we also found that after the culture supernatant of HCC cells in the SUZ12 knockdown group was used to culture HUVECs cells,the formation of vasculogenic mimicry tubular structures in HUVECs cells also increased significantly.Conclusions  SUZ12 has no effect on the proliferation of HCC cells,but it can inhibit the formation of vasculogenic mimicry tubular structures in HCC cells and HUVECs cells.These results suggest that SUZ12 plays a role in cancer inhibition by regulating the angiogenesis of HCCcells and HUVECs cells.
出版者信息








《广州医药》公众号